Drugs / Indigocyanine green dye
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01610739 | Jul 2012 → Jun 2013 | carpal tunnel syndrome | Henry Ford Health System | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indigocyanine green dye | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01610739 ↗ |
| Known as | Indigocyanine green dye (ICG) | “Indigocyanine green dye (ICG)” NCT01610739 ↗ |
| Modality | Diagnostic / imaging agent | “2.5 mg/mL concentration of the imaging agent” NCT01610739 ↗ |
| Route | Intravenous | “3mL of this mixture will be injected intravenously” NCT01610739 ↗ |